In intramolecular [2+2] photocycloaddition reactions, the two tethered olefins can approach each other in a straight or in a crossed fashion. Despite the fact that the latter reaction mode leads...
The title compounds were prepared,
and their reactivity was studied
upon sensitized irradiation at λ = 420 nm. Thioxanthen-9-one
was employed as the sensitizer at a loading of 10 mol % in small-scale
reactions and of 2.5 mol % on a larger scale. Cyclohex-2-enones substituted
by a 2′-propenyloxy, 2′-butenyloxy, 2′-pentenyloxy,
or 2′-methyl-2′-propenyloxy group in the 2-position
gave the products of an intramolecular [2 + 2] photocycloadditon.
The reaction proceeded with high regioselectivity (crossed product)
and perfect diastereoselectivity (nine examples, 34–99% yield).
If the olefin in the tether was trisubstituted (3′-methyl-2′-butenyloxy),
no cycloaddition was observed. Rather, a cyclization with subsequent
hydrogen abstraction occurred (three examples, 65–86% yield).
The results are consistent with a reaction course via a triplet enone
intermediate and the formation of a 1,4-diradical by an initial cyclization.
The analogous cyclopent-2-enones were less prone to an intramolecular
reaction. Instead, decomposition or intermolecular [2 + 2] photocycloaddition
reactions prevailed. In the latter event, two main products were identified
(three examples, 30–43% yield), resulting either from a head-to-head
[2 + 2]-photodimerization or from a twofold [2 + 2] photocycloaddition
of the enone to the olefin. The latter reaction sequence generated
pentacyclic products with a central [1,5]dioxocane ring. The structure
assignment of the two product types was corroborated by a single-crystal
X-ray analysis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.